Skip to main content
Premium Trial:

Request an Annual Quote

Lynx to Provide Gene Expression Services for NIH Database

NEW YORK, Feb. 26 (GenomeWeb News) - Lynx Therapeutics will provide gene expression analysis services worth several million dollars to NIH to build a mouse reference transcriptome database, the company said today.

 

Under the agreement, with SAIC-Frederick on behalf of a consortium of NIH institutes, Lynx will use its Massively Parallel Signature Sequencing technology to study gene expression patterns in mouse tissue samples provided by NIH. The data will enter a reference transcriptome database.

 

Lynx, SAIC-Frederick, and a number of NIH institutes already collaborate on several genome structure and gene expression projects, according to the company.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.